PRTN3 and rheumatoid arthritis: Considering the cross‐reactive nature of ACPA (discussed above in more detail) and the considerable challenge of identifying autoreactive T cells in RA patients, the second scenario seems more promising; however, future studies are required to elucidate the exact mechanism.